614
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Advancing kidney transplantation

Pages 591-593 | Published online: 10 Jan 2014
 

Financial & competing interests disclosure

S Jordan has research grants from CSL Behring and Genentech Inc. to conduct research in desensitization of highly-HLA sensitized patients and also owns a patent USP171,585,B1 titled “IVIG immunosuppression of highly-HLA sensitized patients”. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.